APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biodegradable Coronary Stents

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Biodegradable Coronary Stents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025192 pages

Choose your research edition.

Industry ResearchBiodegradable Coronary Stents Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Biodegradable Coronary Stents Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Biodegradable Coronary Stents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biodegradable Coronary Stents Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Biodegradable Coronary Stents Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Biodegradable Coronary Stents market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Biodegradable Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biodegradable Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biodegradable Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Biodegradable Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biodegradable Coronary Stents include Abbott, Terumo, Shandong Huaan Biotechnology, Boston Scientific, Wego Healthcare, SMT, SINOMED, REVA Medical (1) and Q3 Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Biodegradable Coronary Stents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biodegradable Coronary Stents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biodegradable Coronary Stents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biodegradable Coronary Stents market size, projected growth trends, production technologies, key applications, and end-use industries.

Biodegradable Coronary Stents Segment by Company

Abbott

Terumo

Shandong Huaan Biotechnology

Boston Scientific

Wego Healthcare

SMT

SINOMED

REVA Medical (1)

Q3 Medical

Lepu Medical

Kyoto Medical

Elixir Medical

Cardionovum

Biotronik

Arterius

AMG International

Amaranth Medical

3M

Biodegradable Coronary Stents Segment by Type

Polylactic Acid (PLA)

Magnesium Alloys

Others

Biodegradable Coronary Stents Segment by Application

Percutaneous Coronary Intervention (PCI)

Post-Procedure Management

Drug-Eluting

Biodegradable Coronary Stents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biodegradable Coronary Stents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biodegradable Coronary Stents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biodegradable Coronary Stents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Biodegradable Coronary Stents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Biodegradable Coronary Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Biodegradable Coronary Stents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Biodegradable Coronary Stents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Biodegradable Coronary Stents Industry Trends Table 2. Biodegradable Coronary Stents Industry Drivers Table 3. Biodegradable Coronary Stents Industry Opportunities and Challenges Table 4. Biodegradable Coronary Stents Industry Restraints Table 5. Global Biodegradable Coronary Stents Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Biodegradable Coronary Stents Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Biodegradable Coronary Stents Sales by Manufacturers (Units) & (2021-2026) Table 8. Global Biodegradable Coronary Stents Sales Market Share by Manufacturers Table 9. Global Biodegradable Coronary Stents Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Biodegradable Coronary Stents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Biodegradable Coronary Stents Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Biodegradable Coronary Stents Manufacturers, Product Type & Application Table 13. Global Biodegradable Coronary Stents Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Biodegradable Coronary Stents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Polylactic Acid (PLA) Table 17. Major Manufacturers of Magnesium Alloys Table 18. Major Manufacturers of Others Table 19. Global Biodegradable Coronary Stents Sales by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global Biodegradable Coronary Stents Sales by Type (2021-2026) & (Units) Table 21. Global Biodegradable Coronary Stents Sales by Type (2027-2032) & (Units) Table 22. Global Biodegradable Coronary Stents Sales Market Share by Type (2021-2026) Table 23. Global Biodegradable Coronary Stents Sales Market Share by Type (2027-2032) Table 24. Global Biodegradable Coronary Stents Revenue by Type 2021 VS 2025 VS 2032 (Units) Table 25. Global Biodegradable Coronary Stents Revenue by Type (2021-2026) & (Units) Table 26. Global Biodegradable Coronary Stents Revenue by Type (2027-2032) & (Units) Table 27. Global Biodegradable Coronary Stents Revenue Market Share by Type (2021-2026) Table 28. Global Biodegradable Coronary Stents Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Percutaneous Coronary Intervention (PCI) Table 30. Major Manufacturers of Post-Procedure Management Table 31. Major Manufacturers of Drug-Eluting Table 32. Global Biodegradable Coronary Stents Sales by Application 2021 VS 2025 VS 2032 (Units) Table 33. Global Biodegradable Coronary Stents Sales by Application (2021-2026) & (Units) Table 34. Global Biodegradable Coronary Stents Sales by Application (2027-2032) & (Units) Table 35. Global Biodegradable Coronary Stents Sales Market Share by Application (2021-2026) Table 36. Global Biodegradable Coronary Stents Sales Market Share by Application (2027-2032) Table 37. Global Biodegradable Coronary Stents Revenue by Application 2021 VS 2025 VS 2032 (Units) Table 38. Global Biodegradable Coronary Stents Revenue by Application (2021-2026) & (Units) Table 39. Global Biodegradable Coronary Stents Revenue by Application (2027-2032) & (Units) Table 40. Global Biodegradable Coronary Stents Revenue Market Share by Application (2021-2026) Table 41. Global Biodegradable Coronary Stents Revenue Market Share by Application (2027-2032) Table 42. Global Biodegradable Coronary Stents Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 43. Global Biodegradable Coronary Stents Sales by Region (2021-2026) & (Units) Table 44. Global Biodegradable Coronary Stents Sales Market Share by Region (2021-2026) Table 45. Global Biodegradable Coronary Stents Sales Forecasted by Region (2027-2032) & (Units) Table 46. Global Biodegradable Coronary Stents Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Biodegradable Coronary Stents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 48. North America Biodegradable Coronary Stents Sales by Country (2021-2026) & (Units) Table 49. North America Biodegradable Coronary Stents Sales by Country (2027-2032) & (Units) Table 50. Europe Biodegradable Coronary Stents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 51. Europe Biodegradable Coronary Stents Sales by Country (2021-2026) & (Units) Table 52. Europe Biodegradable Coronary Stents Sales by Country (2027-2032) & (Units) Table 53. Asia Pacific Biodegradable Coronary Stents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 54. Asia Pacific Biodegradable Coronary Stents Sales by Country (2021-2026) & (Units) Table 55. Asia Pacific Biodegradable Coronary Stents Sales by Country (2027-2032) & (Units) Table 56. South America, Middle East and Africa Biodegradable Coronary Stents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 57. South America, Middle East and Africa Biodegradable Coronary Stents Sales by Country (2021-2026) & (Units) Table 58. South America, Middle East and Africa Biodegradable Coronary Stents Sales by Country (2027-2032) & (Units) Table 59. Global Biodegradable Coronary Stents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Biodegradable Coronary Stents Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Biodegradable Coronary Stents Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Biodegradable Coronary Stents Revenue Market Share by Region (2021-2026) Table 63. Global Biodegradable Coronary Stents Revenue Market Share by Region (2027-2032) Table 64. Abbott Company Information Table 65. Abbott Business Overview Table 66. Abbott Biodegradable Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Abbott Biodegradable Coronary Stents Product Portfolio Table 68. Abbott Recent Development Table 69. Terumo Company Information Table 70. Terumo Business Overview Table 71. Terumo Biodegradable Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Terumo Biodegradable Coronary Stents Product Portfolio Table 73. Terumo Recent Development Table 74. Shandong Huaan Biotechnology Company Information Table 75. Shandong Huaan Biotechnology Business Overview Table 76. Shandong Huaan Biotechnology Biodegradable Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Shandong Huaan Biotechnology Biodegradable Coronary Stents Product Portfolio Table 78. Shandong Huaan Biotechnology Recent Development Table 79. Boston Scientific Company Information Table 80. Boston Scientific Business Overview Table 81. Boston Scientific Biodegradable Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Boston Scientific Biodegradable Coronary Stents Product Portfolio Table 83. Boston Scientific Recent Development Table 84. Wego Healthcare Company Information Table 85. Wego Healthcare Business Overview Table 86. Wego Healthcare Biodegradable Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Wego Healthcare Biodegradable Coronary Stents Product Portfolio Table 88. Wego Healthcare Recent Development Table 89. SMT Company Information Table 90. SMT Business Overview Table 91. SMT Biodegradable Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. SMT Biodegradable Coronary Stents Product Portfolio Table 93. SMT Recent Development Table 94. SINOMED Company Information Table 95. SINOMED Business Overview Table 96. SINOMED Biodegradable Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. SINOMED Biodegradable Coronary Stents Product Portfolio Table 98. SINOMED Recent Development Table 99. REVA Medical (1) Company Information Table 100. REVA Medical (1) Business Overview Table 101. REVA Medical (1) Biodegradable Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. REVA Medical (1) Biodegradable Coronary Stents Product Portfolio Table 103. REVA Medical (1) Recent Development Table 104. Q3 Medical Company Information Table 105. Q3 Medical Business Overview Table 106. Q3 Medical Biodegradable Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Q3 Medical Biodegradable Coronary Stents Product Portfolio Table 108. Q3 Medical Recent Development Table 109. Lepu Medical Company Information Table 110. Lepu Medical Business Overview Table 111. Lepu Medical Biodegradable Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Lepu Medical Biodegradable Coronary Stents Product Portfolio Table 113. Lepu Medical Recent Development Table 114. Kyoto Medical Company Information Table 115. Kyoto Medical Business Overview Table 116. Kyoto Medical Biodegradable Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Kyoto Medical Biodegradable Coronary Stents Product Portfolio Table 118. Kyoto Medical Recent Development Table 119. Elixir Medical Company Information Table 120. Elixir Medical Business Overview Table 121. Elixir Medical Biodegradable Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Elixir Medical Biodegradable Coronary Stents Product Portfolio Table 123. Elixir Medical Recent Development Table 124. Cardionovum Company Information Table 125. Cardionovum Business Overview Table 126. Cardionovum Biodegradable Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Cardionovum Biodegradable Coronary Stents Product Portfolio Table 128. Cardionovum Recent Development Table 129. Biotronik Company Information Table 130. Biotronik Business Overview Table 131. Biotronik Biodegradable Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Biotronik Biodegradable Coronary Stents Product Portfolio Table 133. Biotronik Recent Development Table 134. Arterius Company Information Table 135. Arterius Business Overview Table 136. Arterius Biodegradable Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Arterius Biodegradable Coronary Stents Product Portfolio Table 138. Arterius Recent Development Table 139. AMG International Company Information Table 140. AMG International Business Overview Table 141. AMG International Biodegradable Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. AMG International Biodegradable Coronary Stents Product Portfolio Table 143. AMG International Recent Development Table 144. Amaranth Medical Company Information Table 145. Amaranth Medical Business Overview Table 146. Amaranth Medical Biodegradable Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Amaranth Medical Biodegradable Coronary Stents Product Portfolio Table 148. Amaranth Medical Recent Development Table 149. 3M Company Information Table 150. 3M Business Overview Table 151. 3M Biodegradable Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. 3M Biodegradable Coronary Stents Product Portfolio Table 153. 3M Recent Development Table 154. Key Raw Materials Table 155. Raw Materials Key Suppliers Table 156. Biodegradable Coronary Stents Distributors List Table 157. Biodegradable Coronary Stents Customers List Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Biodegradable Coronary Stents Product Image Figure 2. Global Biodegradable Coronary Stents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biodegradable Coronary Stents Market Size (2021-2032) & (US$ Million) Figure 4. Global Biodegradable Coronary Stents Sales (2021-2032) & (Units) Figure 5. Global Biodegradable Coronary Stents Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Biodegradable Coronary Stents Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Polylactic Acid (PLA) Image Figure 9. Magnesium Alloys Image Figure 10. Others Image Figure 11. Global Biodegradable Coronary Stents Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global Biodegradable Coronary Stents Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Biodegradable Coronary Stents Sales Market Share by Type (2021-2032) Figure 14. Global Biodegradable Coronary Stents Revenue by Type (2021 VS 2025 VS 2032) & (Units) Figure 15. Global Biodegradable Coronary Stents Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Biodegradable Coronary Stents Revenue Market Share by Type (2021-2032) Figure 17. Percutaneous Coronary Intervention (PCI) Image Figure 18. Post-Procedure Management Image Figure 19. Drug-Eluting Image Figure 20. Global Biodegradable Coronary Stents Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 21. Global Biodegradable Coronary Stents Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Biodegradable Coronary Stents Sales Market Share by Application (2021-2032) Figure 23. Global Biodegradable Coronary Stents Revenue by Application (2021 VS 2025 VS 2032) & (Units) Figure 24. Global Biodegradable Coronary Stents Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Biodegradable Coronary Stents Revenue Market Share by Application (2021-2032) Figure 26. North America Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 27. North America Biodegradable Coronary Stents Sales Market Share by Country (2021-2032) Figure 28. U.S. Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 29. Canada Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 30. Mexico Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 31. Europe Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 32. Europe Biodegradable Coronary Stents Sales Market Share by Country (2021-2032) Figure 33. Germany Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 34. France Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 35. U.K. Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 36. Italy Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 37. Netherlands Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 38. Asia Pacific Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 39. Asia Pacific Biodegradable Coronary Stents Sales Market Share by Country (2021-2032) Figure 40. China Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 41. Japan Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 42. South Korea Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 43. Southeast Asia Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 44. India Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 45. Australia Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 46. South America, Middle East and Africa Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 47. South America, Middle East and Africa Biodegradable Coronary Stents Sales Market Share by Country (2021-2032) Figure 48. Brazil Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 49. South Africa Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 50. Saudi Arabia Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 51. Turkey Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 52. Argentina Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 53. UAE Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 54. Egypt Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 55. Chile Biodegradable Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 56. Global Biodegradable Coronary Stents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Biodegradable Coronary Stents Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Figure 59. North America Biodegradable Coronary Stents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Figure 61. Europe Biodegradable Coronary Stents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Biodegradable Coronary Stents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Biodegradable Coronary Stents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Biodegradable Coronary Stents Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Biodegradable Coronary Stents Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Polylactic Acid (PLA)
  • Magnesium Alloys
  • Others
Applications
  • Percutaneous Coronary Intervention (PCI)
  • Post-Procedure Management
  • Drug-Eluting
Companies covered
  • Abbott
  • Terumo
  • Shandong Huaan Biotechnology
  • Boston Scientific
  • Wego Healthcare
  • SMT
  • SINOMED
  • REVA Medical (1)
  • Q3 Medical
  • Lepu Medical
  • Kyoto Medical
  • Elixir Medical
  • Cardionovum
  • Biotronik
  • Arterius
  • AMG International
  • Amaranth Medical
  • 3M

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biodegradable Coronary Stents Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biodegradable Coronary Stents Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Biodegradable Coronary Stents Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Biodegradable Coronary Stents Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Biodegradable Coronary Stents Market Dynamics
  1. 2.1 Biodegradable Coronary Stents Industry Trends
  2. 2.2 Biodegradable Coronary Stents Industry Drivers
  3. 2.3 Biodegradable Coronary Stents Industry Opportunities and Challenges
  4. 2.4 Biodegradable Coronary Stents Industry Restraints
3 Biodegradable Coronary Stents Market by Manufacturers
  1. 3.1 Global Biodegradable Coronary Stents Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Biodegradable Coronary Stents Sales by Manufacturers (2021-2026)
  3. 3.3 Global Biodegradable Coronary Stents Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Biodegradable Coronary Stents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Biodegradable Coronary Stents Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Biodegradable Coronary Stents Manufacturers, Product Type & Application
  7. 3.7 Global Biodegradable Coronary Stents Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Biodegradable Coronary Stents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Biodegradable Coronary Stents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Biodegradable Coronary Stents Tier 1, Tier 2, and Tier 3
4 Biodegradable Coronary Stents Market by Type
  1. 4.1 Biodegradable Coronary Stents Type Introduction
  2. 4.1.1 Polylactic Acid (PLA)
  3. 4.1.2 Magnesium Alloys
  4. 4.1.3 Others
  5. 4.2 Global Biodegradable Coronary Stents Sales by Type
  6. 4.2.1 Global Biodegradable Coronary Stents Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Biodegradable Coronary Stents Sales by Type (2021-2032)
  8. 4.2.3 Global Biodegradable Coronary Stents Sales Market Share by Type (2021-2032)
  9. 4.3 Global Biodegradable Coronary Stents Revenue by Type
  10. 4.3.1 Global Biodegradable Coronary Stents Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Biodegradable Coronary Stents Revenue by Type (2021-2032)
  12. 4.3.3 Global Biodegradable Coronary Stents Revenue Market Share by Type (2021-2032)
5 Biodegradable Coronary Stents Market by Application
  1. 5.1 Biodegradable Coronary Stents Application Introduction
  2. 5.1.1 Percutaneous Coronary Intervention (PCI)
  3. 5.1.2 Post-Procedure Management
  4. 5.1.3 Drug-Eluting
  5. 5.2 Global Biodegradable Coronary Stents Sales by Application
  6. 5.2.1 Global Biodegradable Coronary Stents Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Biodegradable Coronary Stents Sales by Application (2021-2032)
  8. 5.2.3 Global Biodegradable Coronary Stents Sales Market Share by Application (2021-2032)
  9. 5.3 Global Biodegradable Coronary Stents Revenue by Application
  10. 5.3.1 Global Biodegradable Coronary Stents Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Biodegradable Coronary Stents Revenue by Application (2021-2032)
  12. 5.3.3 Global Biodegradable Coronary Stents Revenue Market Share by Application (2021-2032)
6 Global Biodegradable Coronary Stents Sales by Region
  1. 6.1 Global Biodegradable Coronary Stents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biodegradable Coronary Stents Sales by Region (2021-2032)
  3. 6.2.1 Global Biodegradable Coronary Stents Sales by Region (2021-2026)
  4. 6.2.2 Global Biodegradable Coronary Stents Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biodegradable Coronary Stents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Biodegradable Coronary Stents Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Biodegradable Coronary Stents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Biodegradable Coronary Stents Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Biodegradable Coronary Stents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Biodegradable Coronary Stents Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Biodegradable Coronary Stents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Biodegradable Coronary Stents Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Biodegradable Coronary Stents Revenue by Region
  1. 7.1 Global Biodegradable Coronary Stents Revenue by Region
  2. 7.1.1 Global Biodegradable Coronary Stents Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Biodegradable Coronary Stents Revenue by Region (2021-2026)
  4. 7.1.3 Global Biodegradable Coronary Stents Revenue by Region (2027-2032)
  5. 7.1.4 Global Biodegradable Coronary Stents Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Biodegradable Coronary Stents Revenue (2021-2032)
  8. 7.2.2 North America Biodegradable Coronary Stents Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Biodegradable Coronary Stents Revenue (2021-2032)
  11. 7.3.2 Europe Biodegradable Coronary Stents Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Biodegradable Coronary Stents Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Biodegradable Coronary Stents Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Biodegradable Coronary Stents Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Biodegradable Coronary Stents Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Biodegradable Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Biodegradable Coronary Stents Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Terumo
  8. 8.2.1 Terumo Company Information
  9. 8.2.2 Terumo Business Overview
  10. 8.2.3 Terumo Biodegradable Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Terumo Biodegradable Coronary Stents Product Portfolio
  12. 8.2.5 Terumo Recent Developments
  13. 8.3 Shandong Huaan Biotechnology
  14. 8.3.1 Shandong Huaan Biotechnology Company Information
  15. 8.3.2 Shandong Huaan Biotechnology Business Overview
  16. 8.3.3 Shandong Huaan Biotechnology Biodegradable Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Huaan Biotechnology Biodegradable Coronary Stents Product Portfolio
  18. 8.3.5 Shandong Huaan Biotechnology Recent Developments
  19. 8.4 Boston Scientific
  20. 8.4.1 Boston Scientific Company Information
  21. 8.4.2 Boston Scientific Business Overview
  22. 8.4.3 Boston Scientific Biodegradable Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Boston Scientific Biodegradable Coronary Stents Product Portfolio
  24. 8.4.5 Boston Scientific Recent Developments
  25. 8.5 Wego Healthcare
  26. 8.5.1 Wego Healthcare Company Information
  27. 8.5.2 Wego Healthcare Business Overview
  28. 8.5.3 Wego Healthcare Biodegradable Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Wego Healthcare Biodegradable Coronary Stents Product Portfolio
  30. 8.5.5 Wego Healthcare Recent Developments
  31. 8.6 SMT
  32. 8.6.1 SMT Company Information
  33. 8.6.2 SMT Business Overview
  34. 8.6.3 SMT Biodegradable Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 SMT Biodegradable Coronary Stents Product Portfolio
  36. 8.6.5 SMT Recent Developments
  37. 8.7 SINOMED
  38. 8.7.1 SINOMED Company Information
  39. 8.7.2 SINOMED Business Overview
  40. 8.7.3 SINOMED Biodegradable Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 SINOMED Biodegradable Coronary Stents Product Portfolio
  42. 8.7.5 SINOMED Recent Developments
  43. 8.8 REVA Medical (1)
  44. 8.8.1 REVA Medical (1) Company Information
  45. 8.8.2 REVA Medical (1) Business Overview
  46. 8.8.3 REVA Medical (1) Biodegradable Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 REVA Medical (1) Biodegradable Coronary Stents Product Portfolio
  48. 8.8.5 REVA Medical (1) Recent Developments
  49. 8.9 Q3 Medical
  50. 8.9.1 Q3 Medical Company Information
  51. 8.9.2 Q3 Medical Business Overview
  52. 8.9.3 Q3 Medical Biodegradable Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Q3 Medical Biodegradable Coronary Stents Product Portfolio
  54. 8.9.5 Q3 Medical Recent Developments
  55. 8.10 Lepu Medical
  56. 8.10.1 Lepu Medical Company Information
  57. 8.10.2 Lepu Medical Business Overview
  58. 8.10.3 Lepu Medical Biodegradable Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lepu Medical Biodegradable Coronary Stents Product Portfolio
  60. 8.10.5 Lepu Medical Recent Developments
  61. 8.11 Kyoto Medical
  62. 8.11.1 Kyoto Medical Company Information
  63. 8.11.2 Kyoto Medical Business Overview
  64. 8.11.3 Kyoto Medical Biodegradable Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Kyoto Medical Biodegradable Coronary Stents Product Portfolio
  66. 8.11.5 Kyoto Medical Recent Developments
  67. 8.12 Elixir Medical
  68. 8.12.1 Elixir Medical Company Information
  69. 8.12.2 Elixir Medical Business Overview
  70. 8.12.3 Elixir Medical Biodegradable Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Elixir Medical Biodegradable Coronary Stents Product Portfolio
  72. 8.12.5 Elixir Medical Recent Developments
  73. 8.13 Cardionovum
  74. 8.13.1 Cardionovum Company Information
  75. 8.13.2 Cardionovum Business Overview
  76. 8.13.3 Cardionovum Biodegradable Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cardionovum Biodegradable Coronary Stents Product Portfolio
  78. 8.13.5 Cardionovum Recent Developments
  79. 8.14 Biotronik
  80. 8.14.1 Biotronik Company Information
  81. 8.14.2 Biotronik Business Overview
  82. 8.14.3 Biotronik Biodegradable Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Biotronik Biodegradable Coronary Stents Product Portfolio
  84. 8.14.5 Biotronik Recent Developments
  85. 8.15 Arterius
  86. 8.15.1 Arterius Company Information
  87. 8.15.2 Arterius Business Overview
  88. 8.15.3 Arterius Biodegradable Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Arterius Biodegradable Coronary Stents Product Portfolio
  90. 8.15.5 Arterius Recent Developments
  91. 8.16 AMG International
  92. 8.16.1 AMG International Company Information
  93. 8.16.2 AMG International Business Overview
  94. 8.16.3 AMG International Biodegradable Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 AMG International Biodegradable Coronary Stents Product Portfolio
  96. 8.16.5 AMG International Recent Developments
  97. 8.17 Amaranth Medical
  98. 8.17.1 Amaranth Medical Company Information
  99. 8.17.2 Amaranth Medical Business Overview
  100. 8.17.3 Amaranth Medical Biodegradable Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Amaranth Medical Biodegradable Coronary Stents Product Portfolio
  102. 8.17.5 Amaranth Medical Recent Developments
  103. 8.18 3M
  104. 8.18.1 3M Company Information
  105. 8.18.2 3M Business Overview
  106. 8.18.3 3M Biodegradable Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 3M Biodegradable Coronary Stents Product Portfolio
  108. 8.18.5 3M Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Biodegradable Coronary Stents Value Chain Analysis
  2. 9.1.1 Biodegradable Coronary Stents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Biodegradable Coronary Stents Production Mode & Process
  6. 9.2 Biodegradable Coronary Stents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Biodegradable Coronary Stents Distributors
  9. 9.2.3 Biodegradable Coronary Stents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst